AstraZeneca boosted by good results for biotech asthma drug

LONDON, May 17 (Reuters) - AstraZeneca's drive to

rebuild its portfolio of new medicines received a boost on

Tuesday with positive results for a biotech drug for severe

asthma that the company has...

Read more